Licences of 20 medical stores suspended after inspections
Drug Control Department inspects 120 medical stores; 32 NDPS cases and 63 arrests recorded in 2026 so far The district administration has intensified action against illegal drug sale and distribution,…
Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore
NEW DELHI: Global investment firm Bain Capital has divested nearly a 1 per cent stake in Emcure Pharmaceuticals for over Rs 289 crore through open market transactions, according to the…
Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal
Sun Pharmaceutical Industries Ltd has announced that it has entered into a definitive agreement under which it will acquire all outstanding shares of Organon for $14.00 per share in an…
HP accounts for 47 inferior drugs in March alert
Kullu: In an alert issued for the month of March, the Central Drugs Standard Control Organisation (CDSCO) has declared a total of 141 drugs to be of substandard quality. Out…
Civil society group SAM calls for greater transparency involving clinical trials
The group had approached the Supreme Court, raising concerns on clinical trials in a Public Interest Litigation in 2012 Civil society group Swasthya Adhikar Manch (SAM) has called for greater…
Different packaging, typos expose fake Mounjaro racket
Gurugram: Colour dissimilarity to typographical errors… conspicuous differences in the packaging of counterfeit Mounjaro injections led the Drugs Control Office to crack down on the illicit sale and production of…
Rajasthan Bans 7 Sub-Standard Medicines
Prioritising public health and patient safety, the Commissionerate of Food Safety and Drug Control, Rajasthan, has issued an alert regarding seven medicines and declared them “Not of Standard Quality”. Prioritising…
ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection
OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…
Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant
Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…
Obesity drug market to gain as Indians pop the pill and Chinese bring more
Mumbai: A flood of oral GLP1 weight-loss pills, including from China, may redraw India’s obesity treatment market by this year-end, said industry executives and top endocrinologists. Nearly a dozen oral…
